Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of BAY 43-9006
NCT00119639
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Kidney Diseases
Interventions
DRUG:
Sorafenib (BAY43-9006, Nexavar)
Sponsor
Bayer